About Halcyon Biomedical
Halcyon Biomedical is a company based in Friendswood (United States) founded in 2013.. Halcyon Biomedical offers products and services including Lymphocyte Isolation, Large Cell Enrichment, and WBC Isolation. Halcyon Biomedical operates in a competitive market with competitors including Hemex Health, BioMedomics, ShanMukha Innovations, Silver Lake Research Corporation and HemaCore, among others.
- Headquarter Friendswood, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Halcyon Biomedical Incorporated
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$749.4 K (USD), Grant
May 01, 2020
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Halcyon Biomedical
Halcyon Biomedical offers a comprehensive portfolio of products and services, including Lymphocyte Isolation, Large Cell Enrichment, and WBC Isolation. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for isolating lymphocytes from whole blood samples
Process for enriching monocytes and CTC from undiluted blood
Method for isolating white blood cells from leukopaks
Funding Insights of Halcyon Biomedical
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $749,400
-
First Round
First Round
(06 Aug 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Grant - Halcyon Biomedical | Valuation |
investors |
|
| Feb, 2019 | Amount | Grant - Halcyon Biomedical | Valuation |
investors |
|
| Aug, 2014 | Amount | Grant - Halcyon Biomedical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Halcyon Biomedical
Halcyon Biomedical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and America’s Seed Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Halcyon Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Halcyon Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Halcyon Biomedical Comparisons
Competitors of Halcyon Biomedical
Halcyon Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemex Health, BioMedomics, ShanMukha Innovations, Silver Lake Research Corporation and HemaCore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Platform providing care devices for the detection of tropical diseases
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic systems for blood-based disorders are developed.
|
|
| domain | founded_year | HQ Location |
Affordable point-of-care diagnostic solutions are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Custom antibodies and diagnostics are developed for various applications.
|
|
| domain | founded_year | HQ Location |
Instruments and assays for blood disorders are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Halcyon Biomedical
When was Halcyon Biomedical founded?
Halcyon Biomedical was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Halcyon Biomedical located?
Halcyon Biomedical is headquartered in Friendswood, United States. It is registered at Friendswood, Texas, United States.
What does Halcyon Biomedical do?
Halcyon Biomedical develops diagnostic solutions for hematological disorders. Its flagship product utilizes differences in blood spread between normal blood and blood from a patient with sickle cell anemia, as seen on a chromatography paper, to diagnose the disease. In addition, the company is also developing a portable whole blood separator, a microfluidic device that enables separation of leukocytes from platelet-rich plasma, a lab-on-chip device for the selective enrichment of cell types in whole blood, a cell sorter focused on circulating tumor cells, and a platform for the enrichment of exosomes.
Who are the top competitors of Halcyon Biomedical?
Halcyon Biomedical's top competitors include Hemex Health, Silver Lake Research Corporation and BioMedomics.
What products or services does Halcyon Biomedical offer?
Halcyon Biomedical offers Lymphocyte Isolation, Large Cell Enrichment, and WBC Isolation.
Who are Halcyon Biomedical's investors?
Halcyon Biomedical has 2 investors. Key investors include HHS, and America’s Seed Fund.